Endoscopic Devices - United Arab Emirates

In the United Arab Emirates, revenue in the Endoscopic Devices market market is projected to reach US$142.60m in 2024.
The revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 9.67%, which will result in a market volume of US$226.20m by 2029.
In a global context, the United States will generate the most revenue, amounting to US$10.39bn in 2024.
The United Arab Emirates is witnessing a surge in demand for advanced endoscopic devices, driven by increasing healthcare investments and a growing focus on minimally invasive procedures.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in the United Arab Emirates is witnessing considerable growth, fueled by advancements in minimally invasive procedures, increasing prevalence of chronic diseases, and rising demand for outpatient surgeries, enhancing patient care and accessibility.

Customer preferences: Consumers in the United Arab Emirates are increasingly prioritizing personalized healthcare solutions, driving demand for advanced endoscopic devices that offer tailored treatments. The rise in health awareness, particularly among younger demographics, is prompting a preference for minimally invasive procedures that ensure quicker recovery times and less discomfort. Additionally, cultural shifts towards preventive healthcare are encouraging more individuals to seek outpatient surgeries, further propelling the endoscopic devices market and enhancing overall patient care experiences.

Trends in the market: In the United Arab Emirates, the Endoscopic Devices Market is experiencing a notable shift towards advanced imaging technologies, enhancing precision in minimally invasive procedures. As healthcare providers increasingly adopt robotic-assisted endoscopic systems, there is a growing emphasis on improved surgical outcomes and reduced patient recovery times. Furthermore, the integration of artificial intelligence in diagnostic endoscopy is streamlining workflows and enhancing decision-making. These trends underscore the significance of innovation in patient-centric care, compelling industry stakeholders to invest in R&D and collaborate with technology firms to stay competitive in this evolving landscape.

Local special circumstances: In the United Arab Emirates, the Endoscopic Devices Market is shaped by a combination of factors unique to the region. The UAE’s strategic location as a healthcare hub attracts international medical firms, fostering collaboration and innovation. Additionally, the high standard of living and a culturally diverse population demand advanced medical solutions that cater to various needs. Regulatory frameworks are also evolving, with the government prioritizing health technology assessments to ensure patient safety and efficacy, further influencing market dynamics and driving the adoption of cutting-edge endoscopic technologies.

Underlying macroeconomic factors: The Endoscopic Devices Market in the United Arab Emirates is significantly influenced by macroeconomic factors such as economic diversification, increasing healthcare expenditure, and growing public-private partnerships. As the UAE continues to invest in its healthcare infrastructure, the demand for advanced medical technologies, including endoscopic devices, is on the rise. Additionally, global economic trends, such as the increased focus on minimally invasive procedures, align with the local market's needs. The government's commitment to enhancing healthcare quality and safety through regulatory reforms further supports the adoption of innovative endoscopic solutions, fostering a conducive environment for market growth.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.